Learn / MLTX
NASDAQ: MLTX
MoonLake Immunotherapeutics (MLTX) stock, explained like you're 5
MoonLake Immunotherapeutics trades on the Nasdaq under the ticker MLTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 921 million dollars.
- Ticker
- MLTX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 921 million dollars
Is MoonLake Immunotherapeutics a small, medium or large cap company?
No. MoonLake Immunotherapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 921 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How MoonLake Immunotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MLTX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- MoonLake’s sonelokimab faces regulatory, commercial tests, RBC says (MLTX:NASDAQ) (Seeking Alpha)
- MLTX Stock Garners Retail Attention On Buyout Speculation, Positive Skin Condition Trial Data (Stocktwits)
- MLTX Jan 2029 12.000 put (MLTX290119P00012000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Why is MoonLake Immunotherapeutics stock plunging today? (Investing.com)
- MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event (Stocktwits)
Follow MLTX in your daily brief
Each trading day at 5 PM ET we post what happened to MoonLake Immunotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MLTX
Questions about MoonLake Immunotherapeutics stock
What does MoonLake Immunotherapeutics do?
MoonLake Immunotherapeutics trades on the Nasdaq under the ticker MLTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 921 million dollars.
What is the ticker symbol for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics trades under the ticker MLTX on the Nasdaq.
What is MoonLake Immunotherapeutics's market cap?
MoonLake Immunotherapeutics is a small cap stock with a market cap of about 921 million dollars.
How does MoonLake Immunotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MLTX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MLTX stock every day?
Add MLTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.